Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
The neuraminidase-inhibition (NI) assay is a laboratory procedure for the identification of the neuraminidase (NA) glycoprotein subtype in influenza viruses or the NA subtype specificity of antibodies to influenza virus. A serological procedure for subtyping the NA glycoprotein is critical for the identification and classification of avian influenza (AI) viruses. The macro-procedure was first described in 1961 by D. Aminoff et al. [2] and was later modified to a microtiter plate procedure (micro-NI) by Van Deusen et al. [4]. The micro-NI procedure reduces the quantity of reagents required, permits the antigenic classification of many isolates simultaneously, and eliminates the spectrophotometric interpretation of results. Although the macro-NI has been shown to be more sensitive than the micro-NI, the micro-NI test is very suitable for testing sera for the presence of NA antibodies and has proven to be a practical and rapid method for virus classification. This chapter will provide an overview of the USDA-validated micro-NI procedure for the identification of subtype-specific NA in AIV and antibodies.
Pedersen
Janice C
JC
Avian Viruses Section, Diagnostic Virology Laboratory, National Veterinary Services Laboratories, US Department of Agriculture, Ames, IA, USA.
D000818:Animals; D000918:Antibody Specificity / Q000276:immunology*; D001717:Birds; D009980:Influenza A virus / Q000201:enzymology* / Q000276:immunology; D005585:Influenza in Birds / Q000821:virology; D008954:Models, Biological; D009439:Neuraminidase / Q000276:immunology / Q000378:metabolism*
D009439:Neuraminidase